Characteristics of homologous recombination repair pathway genes mutation in ovarian cancers [0.03%]
同源重组修复通路基因突变的卵巢癌特征分析
Zongbi Yi,Min Chen,Shaoxing Sun et al.
Zongbi Yi et al.
Background: Few studies have investigated the characteristics of non-BRCA homologous recombination repair (HRR) pathway somatic mutations, and the impact of these mutations on efficacy of treatment in ovarian cancer patie...
Prognostic value of lactate transporter SLC16A1 and SLC16A3 as oncoimmunological biomarkers associating tumor metabolism and immune evasion in glioma [0.03%]
乳酸转运蛋白SLC16A1和SLC16A3作为胶质瘤肿瘤代谢和免疫逃逸的肿瘤免疫生物标志物的预后价值
Ting Zhu,Xiaoqin Ge,Shengping Gong et al.
Ting Zhu et al.
Background: Hypoxic microenvironment is immunosuppressive and protumorigenic, and elevated lactate is an intermediary in the modulation of immune responses. However, as critical lactate transporters, the role of SLC16A1 a...
Promoting the application of pediatric radiomics via an integrated medical engineering approach [0.03%]
通过医工结合推进儿科影像组学研究及应用
Haige Zheng,Fang Wang,Yang Li et al.
Haige Zheng et al.
Radiomics is widely used in adult tumors but has been rarely applied to the field of pediatrics. Promoting the application of radiomics in pediatric diseases, especially in the early diagnosis and stratified treatment of tumors, is of great...
Global trends of cancer: The role of diet, lifestyle, and environmental factors [0.03%]
全球癌症发病趋势：饮食、生活方式和环境因素的作用
Hassan Bahrami,Majid Tafrihi
Hassan Bahrami
Effective treatment of cancer requires understanding the nature of the disease and accurately addressing the main root causes. General risk factors for cancer include poor nutrition, an acidogenic diet, an unhealthy lifestyle, and exposure ...
The antiferroptotic role of TRIM7: Molecular mechanism and synergistic effect with temozolomide [0.03%]
TRIM7的抗铁死亡作用：分子机制及其与替莫唑胺的协同效应
Luyao Wang,Rongyang Xu,Chengying Huang et al.
Luyao Wang et al.
Nuclear receptor coactivator 4 (NCOA4) protein is a selective cargo receptor that plays a crucial role in ferritinophagy by targeting and delivering the ferritin iron storage protein to lysosomes for degradation and releasing iron. TRIM7 ov...
Progress in research on ultrasound radiomics for predicting the prognosis of breast cancer [0.03%]
乳腺癌预后评估的超声影像组学研究进展
Xuantong Gong,Xuefeng Liu,Xiaozheng Xie et al.
Xuantong Gong et al.
Breast cancer is the most common malignant tumor and the leading cause of cancer-related deaths in women worldwide. Effective means of predicting the prognosis of breast cancer are very helpful in guiding treatment and improving patients' s...
Correction to "Pooled analyses of randomized controlled trials on pyrotinib plus capecitabine and a rethink of the first-line options for HER2-positive relapsed or metastatic breast cancer" [0.03%]
对“吡咯替尼联合卡培他滨治疗复发或转移性HER2阳性乳腺癌的随机对照试验合并分析及重新思考”的更正
[This corrects the article DOI: 10.1002/cai2.21.]. © 2023 The Authors. Cancer Innovation published by John Wiley & Sons Ltd. on behalf of Tsinghua Unive...
Published Erratum
Cancer innovation. 2023 Apr 11;2(4):318. DOI:10.1002/cai2.69 2023
Resveratrol activation of SIRT1/MFN2 can improve mitochondria function, alleviating doxorubicin-induced myocardial injury [0.03%]
白藜芦醇通过激活SIRT1/MFN2改善线粒体功能从而缓解多柔比星致心肌损伤的作用研究
Qingling Zhang,Yunpeng Zhang,Bingxin Xie et al.
Qingling Zhang et al.
Background: Doxorubicin is a widely used cytotoxic chemotherapy agent for treating different malignancies. However, its use is associated with dose-dependent cardiotoxicity, causing irreversible myocardial damage and sign...
Bibliometric and visualized analysis of applying tumor markers in lung cancer diagnosis from 2000 to 2022 [0.03%]
2000年至2022年肿瘤标志物在肺癌诊断中应用的 bibliometri 和可视化分析
Shi-Peng Ke,Si-Mei Chen,Yi Jiang et al.
Shi-Peng Ke et al.
Background: Lung cancer (LC) is the leading cause of cancer-related deaths worldwide. Tumor marker (TM) detection can indicate the existence and growth of a tumor and has therefore been used extensively for diagnosing LC....
Survival nomograms for simultaneous resection of primary and hepatic lesions without neoadjuvant chemotherapy in patients with resectable colorectal liver metastasis [0.03%]
可切除结直肠癌肝转移患者同期手术的无新辅助化疗生存预测模型
Yu-Juan Jiang,Si-Cheng Zhou,Zi-Xing Zhu et al.
Yu-Juan Jiang et al.
Background: No well-performing nomogram has been developed specifically to predict individual-patient cancer-specific survival (CSS) and overall survival (OS) among patients with resectable colorectal liver metastasis (CR...